Epiberberine inhibits Helicobacter pylori and reduces host apoptosis and inflammatory damage by down-regulating urease expression.

With dramatically increasing antibiotic resistance in Helicobacter pylori (H. pylori), it is urgent to find alternative therapeutic agents. Rhizoma Coptidis is a traditional Chinese medicine for gastrointestinal diseases and shows excellent anti- H. pylori effect. Epiberberine (EPI), as one of the m...

Full description

Bibliographic Details
Published in:Journal of Ethnopharmacology Vol. 318
Main Authors: Wu, Huimin, Xie, Xinrui, Tang, Qin, Huang, Ting, Tang, Xiang, Jiao, Baihua, Wang, Rui, Zhu, Xinhu, Ye, Xiaoli, Ma, Hang, Li, Xuegang
Format: research Journal Article
Published: Elsevier B.V. Jan2024:Part B
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171921249&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 171921249
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03788741
        3MS
      jtl: Journal of Ethnopharmacology
      issn: 03788741
      maglogo: N
    pubinfo:
      dt: Jan2024:Part B
      vid: 318
      pid: 1004
      pub: Elsevier B.V.
    artinfo:
      ui:
        171921249
        171921249
        171921249
        10.1016/j.jep.2023.117046
        171921249
      ppct: 1
      formats:
      tig:
        atl: Epiberberine inhibits Helicobacter pylori and reduces host apoptosis and inflammatory damage by down-regulating urease expression.
      aug:
        au:
          Wu, Huimin
          Xie, Xinrui
          Tang, Qin
          Huang, Ting
          Tang, Xiang
          Jiao, Baihua
          Wang, Rui
          Zhu, Xinhu
          Ye, Xiaoli
          Ma, Hang
          Li, Xuegang
        affil: Engineering Research Center of Coptis Development and Utilization (Ministry of Education), College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China
      sug:
        subj:
          Alkaloids Pharmacodynamics
          Helicobacter Pylori
          Apoptosis
          Inflammation
          Urease Analysis
          Human
          Microbial Culture and Sensitivity Tests
          In Vitro Studies
          In Vivo Studies
          Molecular Docking Simulation
          Reverse Transcriptase Polymerase Chain Reaction
          Cell Viability
          Blotting, Western
      ab: With dramatically increasing antibiotic resistance in Helicobacter pylori (H. pylori), it is urgent to find alternative therapeutic agents. Rhizoma Coptidis is a traditional Chinese medicine for gastrointestinal diseases and shows excellent anti- H. pylori effect. Epiberberine (EPI), as one of the major alkaloids of Rhizoma Coptidis, has been reported to have urease-inhibiting activity, but its scavenging effect on H. pylori and the potential mechanism remain unclear. To investigate the inhibitory effect of EPI on H. pylori and explore its multi-action on Helicobacter pylori urease (HPU). Using minimum inhibitory concentration (MIC) assay, minimum bactericidal concentration (MBC) assay, growth inhibition kinetics assay, bacterial resistance development, transmission electron microscope (TEM) assay, and animal experiments to investigate the inhibitory effect of EPI on H. pylori in vitro and in vivo. Using the Berthelot method, molecular docking and thermal displacement experiments to verify that EPI inhibits urease activity by interacting with HPU. Using transcriptome data, Real-Time PCR (RT-PCR) experiments to investigate the alterations in the expression of urease subunit ureB gene after EPI treatment. Using MTT cell viability assay, Hoechst 33342 staining method, JC-1 reagent detection method, western blot experiments, and Griess method to investigate the anti-apoptosis and anti-inflammation actions of EPI on gastric epithelial cells (GES-1) induced by HPU. In vitro experiments proved that EPI has significant anti- H. pylori activity without drug resistance, induces H. pylori fragmentation and apoptosis. In vivo experiments showed that EPI has a certain clearance effect of H. pylori, and can reduce gastric inflammation caused by H. pylori infection. Transcriptome data, RT-PCR experiments, and other experiments demonstrate that EPI has a triple effect: (1) inhibiting the expression of HPU subunits ureB, (2) directly inhibiting urease activity by interacting with HPU, and (3) inhibiting HPU-induced apoptosis and inflammation in GES-1. EPI is an excellent anti- H. pylori agent and reduces host apoptosis and inflammation by inhibiting the activity of urease and down-regulating the expression of ureB. [Display omitted]
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N